Title | Type | ![]() |
H index | Total Docs. (2005) | Total Docs. (3years) | Total Refs. (2005) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2005) | %Female (2005) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
29 | Journal of Antibiotics | journal | 0.784 Q2 | 92 | 107 | 402 | 1781 | 601 | 344 | 1.54 | 16.64 | 24.68 | ![]() |
28 | Expert Review of Vaccines![]() | journal | 0.801 Q2 | 105 | 82 | 240 | 5937 | 592 | 220 | 2.60 | 72.40 | 28.76 | ![]() |
27 | Drug Discovery Today | journal | 0.823 Q2 | 215 | 320 | 1091 | 9453 | 2504 | 838 | 2.21 | 29.54 | 24.25 | ![]() |
26 | American Journal of Respiratory Medicine | journal | 0.841 Q2 | 34 | 0 | 93 | 0 | 271 | 87 | 3.62 | 0.00 | 0.00 | ![]() |
25 | Pharmacogenomics | journal | 0.886 Q2 | 100 | 89 | 277 | 4121 | 787 | 240 | 2.68 | 46.30 | 33.62 | ![]() |
24 | PharmacoEconomics![]() | journal | 0.904 Q2 | 118 | 110 | 331 | 4430 | 910 | 312 | 2.64 | 40.27 | 36.13 | ![]() |
23 | Current Opinion in Investigational Drugs | journal | 0.921 Q2 | 83 | 148 | 571 | 8853 | 1617 | 531 | 3.06 | 59.82 | 26.81 | ![]() |
22 | Expert Opinion on Biological Therapy | journal | 0.943 Q1 | 102 | 140 | 378 | 11936 | 1061 | 365 | 2.90 | 85.26 | 25.28 | ![]() |
21 | Journal of Psychopharmacology | journal | 0.956 Q1 | 135 | 120 | 218 | 4648 | 617 | 194 | 2.95 | 38.73 | 36.71 | ![]() |
20 | Expert Opinion on Therapeutic Targets | journal | 0.999 Q1 | 106 | 89 | 169 | 10586 | 417 | 159 | 2.62 | 118.94 | 28.57 | ![]() |
19 | British Journal of Clinical Pharmacology | journal | 1.038 Q1 | 167 | 208 | 623 | 4715 | 1933 | 526 | 2.94 | 22.67 | 29.05 | ![]() |
18 | Drug Safety | journal | 1.053 Q1 | 140 | 86 | 272 | 5982 | 1158 | 258 | 4.11 | 69.56 | 41.34 | ![]() |
17 | Expert Opinion on Investigational Drugs | journal | 1.059 Q1 | 117 | 137 | 423 | 11445 | 1588 | 412 | 3.61 | 83.54 | 26.64 | ![]() |
16 | Journal of Immune Based Therapies and Vaccines | journal | 1.060 Q1 | 21 | 7 | 14 | 365 | 29 | 13 | 2.07 | 52.14 | 34.78 | ![]() |
15 | American Journal of PharmacoGenomics | journal | 1.106 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ![]() |
14 | Current Opinion in Molecular Therapeutics | journal | 1.121 Q1 | 67 | 82 | 268 | 4057 | 793 | 242 | 2.85 | 49.48 | 30.67 | ![]() |
13 | Current Opinion in Drug Discovery and Development | journal | 1.278 Q1 | 85 | 73 | 265 | 3560 | 1024 | 250 | 4.18 | 48.77 | 18.11 | ![]() |
12 | International Journal of Neuropsychopharmacology![]() | journal | 1.337 Q1 | 125 | 73 | 175 | 2974 | 612 | 152 | 3.21 | 40.74 | 31.23 | ![]() |
11 | Pharmacogenomics Journal | journal | 1.395 Q1 | 95 | 45 | 176 | 1837 | 690 | 149 | 3.66 | 40.82 | 35.16 | ![]() |
10 | Receptors and Channels | journal | 1.445 Q1 | 44 | 0 | 90 | 0 | 264 | 85 | 2.22 | 0.00 | 0.00 | ![]() |
9 | Antiviral Therapy | journal | 1.694 Q1 | 93 | 127 | 241 | 4818 | 931 | 229 | 4.12 | 37.94 | 42.45 | ![]() |
8 | Clinical Pharmacokinetics | journal | 1.745 Q1 | 184 | 86 | 248 | 6300 | 1723 | 245 | 7.12 | 73.26 | 31.92 | ![]() |
7 | Journal of Antimicrobial Chemotherapy | journal | 1.768 Q1 | 221 | 444 | 1354 | 11452 | 5494 | 1138 | 4.06 | 25.79 | 39.58 | ![]() |
6 | Neuropharmacology | journal | 2.034 Q1 | 191 | 250 | 728 | 11590 | 3108 | 727 | 4.07 | 46.36 | 36.02 | ![]() |
5 | Neuropsychopharmacology | journal | 2.583 Q1 | 249 | 238 | 727 | 13808 | 4232 | 688 | 5.53 | 58.02 | 34.51 | ![]() |
4 | Trends in Pharmacological Sciences | journal | 4.267 Q1 | 244 | 106 | 404 | 5469 | 3362 | 340 | 9.18 | 51.59 | 23.58 | ![]() |
3 | Nature Reviews Drug Discovery | journal | 7.654 Q1 | 391 | 339 | 809 | 8032 | 5111 | 255 | 5.62 | 23.69 | 15.46 | ![]() |
2 | Expert Opinion on Drug Metabolism and Toxicology | journal | 100 | 51 | 0 | 5082 | 0 | 0 | 0.00 | 99.65 | 28.07 | ![]() | |
1 | Molecular Diagnosis and Therapy | journal | 68 | 61 | 161 | 4159 | 452 | 159 | 2.90 | 68.18 | 38.12 | ![]() |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®